Cite
HARVARD Citation
Glintborg, B. et al. (2019). To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry. Annals of the rheumatic diseases. 78 (2), pp. 192-200. [Online].